Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Hepatitis C Virus (HCV) screening in adults, effective May 15, 2026. Here's what billing teams need to do.
CMS hepatitis C virus screening coverage policy has been updated — and if your practice bills Medicare for preventive screening services, this change deserves your attention before the effective date of May 15, 2026. The Centers for Medicare & Medicaid Services has modified the national coverage framework for adult HCV screening, which affects how practices document and bill these encounters. The policy does not carry a traditional NCD or LCD policy code in the standard format, but it governs Medicare reimbursement for one of the most frequently ordered adult preventive screenings in primary care.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Screening for Hepatitis C Virus (HCV) in Adults |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium-High |
| Specialties Affected | Primary care, internal medicine, gastroenterology, infectious disease, federally qualified health centers (FQHCs), rural health clinics (RHCs) |
| Key Action | Audit your HCV screening billing workflows and documentation templates before May 15, 2026 to confirm alignment with updated medical necessity criteria |
CMS Hepatitis C Virus Screening Coverage Criteria and Medical Necessity Requirements 2026
CMS covers HCV screening for Medicare beneficiaries as a preventive benefit under the Affordable Care Act's zero-cost-sharing framework. The coverage policy aligns with U.S. Preventive Services Task Force (USPSTF) recommendations, which form the clinical backbone of what CMS considers medically necessary for this screening.
The core medical necessity criteria under the existing — and now modified — framework center on two populations. First, adults aged 18 to 79 who have never been screened for HCV are eligible for a one-time screening. Second, adults at increased risk for HCV infection — including those with a history of injection drug use or other documented risk factors — are eligible for periodic repeat screening.
The modification effective May 15, 2026 signals a policy refinement rather than a wholesale reversal. CMS periodically updates these coverage documents to reflect USPSTF grade changes, clinical guideline updates, or to clarify documentation expectations that have generated claim denial patterns. Given that the USPSTF reaffirmed its Grade B recommendation for HCV screening in adults aged 18 to 79 in recent years, the most likely driver of this modification is a documentation or coverage criteria clarification — not a benefit elimination.
Prior authorization is not required for HCV screening under Medicare when billed as a preventive service. That's been consistent with CMS policy, and nothing in the modification framework changes that. However, medical necessity documentation still matters — especially when a beneficiary is outside the standard 18-to-79 age band or when a practice bills for repeat screening without documenting a qualifying risk factor.
If your billing team codes HCV screening under the preventive benefit, you need to confirm that your clinical documentation clearly supports the indication: one-time screening for the age-eligible population, or documented risk-based criteria for repeat testing. Payers — including Medicare — will look for that distinction when a claim hits the system more than once for the same beneficiary.
CMS HCV Screening Exclusions and Non-Covered Indications
CMS does not cover HCV screening as a preventive benefit for beneficiaries outside the age range of 18 to 79 without additional documented clinical justification. Screening ordered purely for clinical curiosity — without a documented risk factor or age-based eligibility — will not satisfy medical necessity and will generate a claim denial.
Diagnostic HCV testing is a separate billing category entirely. If a patient presents with symptoms consistent with hepatitis C infection — fatigue, jaundice, elevated liver enzymes — that encounter should be billed as a diagnostic service, not a preventive screening. The distinction matters both for coverage and for cost-sharing: diagnostic testing carries Medicare cost-sharing obligations, while confirmed preventive screening under the USPSTF Grade B recommendation is covered at zero cost to the beneficiary.
Repeat screening without documented risk factors is another common denial trigger. If your practice sees high volumes of patients with substance use history, make sure your EHR templates are capturing the specific risk factors that justify repeat testing. A blank "HCV screening" order without supporting documentation is a liability.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| One-time HCV screening, adults aged 18–79 | Covered | See Affected Codes section | Zero cost-sharing applies; no prior auth required |
| Repeat HCV screening, high-risk adults (e.g., injection drug use history) | Covered | See Affected Codes section | Requires documented risk factor in medical record |
| HCV screening, adults over 79 without documented risk factors | Not Covered | N/A | Outside standard coverage criteria |
| Diagnostic HCV testing (symptomatic presentation) | Covered (diagnostic benefit, not preventive) | See Affected Codes section | Patient cost-sharing applies; bill under diagnostic, not preventive |
| Repeat screening without documented risk factor | Not Covered | N/A | Claim denial risk without qualifying documentation |
CMS Hepatitis C Virus Screening Billing Guidelines and Action Items 2026
The real issue here is documentation. Most claim denials for HCV screening don't happen because the screening wasn't covered — they happen because the documentation didn't support the billed indication. Here's what your billing team should do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Audit your EHR screening templates. Pull the documentation template your providers use when ordering HCV screening. Confirm it captures the patient's age, whether this is a first-time or repeat screening, and — for repeat screenings — the specific risk factor that qualifies the patient. A generic "preventive labs" note does not meet medical necessity documentation standards. |
| 2 | Separate preventive and diagnostic encounters in your charge capture. HCV screening billed as preventive carries zero cost-sharing for Medicare beneficiaries. HCV testing billed as diagnostic does not. Your charge capture workflow should require the coder or biller to confirm which category applies before the claim goes out. Mixing these up creates both billing errors and patient satisfaction problems when an unexpected bill arrives. |
| 3 | Review your beneficiary age filters. Run a report on your Medicare HCV screening claims from the past 12 months. Flag any claims for beneficiaries over 79 years old. If those claims went out without documented risk factor justification, assess your denial exposure and adjust your protocols before the May 15, 2026 effective date. |
| 4 | Train your front-end staff on the zero-cost-sharing rule. Patients in the 18-to-79 age band should not be charged a copay or coinsurance for a preventive HCV screening under Medicare. If your front desk is collecting cost-sharing on these encounters, you have both a billing error and a compliance issue. Fix it before May 15, 2026. |
| 5 | Confirm your FQHC and RHC billing workflows if applicable. Federally Qualified Health Centers and Rural Health Clinics bill under different reimbursement structures — the Prospective Payment System (PPS) rate for FQHCs and the all-inclusive rate for RHCs. The coverage policy criteria still apply, but the billing mechanics differ. If your team supports one of these practice types, confirm your workflows against the updated policy with your billing consultant before the effective date. |
| 6 | Don't rely on a prior authorization workflow for this benefit. Prior authorization is not required for preventive HCV screening under Medicare. If your practice has inadvertently built a PA step into your preventive screening process, remove it — it's creating unnecessary friction and may be delaying patient care. |
If you're unsure how this modification applies to your specific payer mix — particularly if you have commercial payers who model their HCV screening coverage on CMS policy — talk to your compliance officer before May 15, 2026. Commercial payers sometimes follow USPSTF-aligned coverage with a lag, and your billing guidelines for those payers may need separate review.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for HCV Screening Under This Policy
The policy document for this modification does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for CMS coverage policy modifications that operate at the national level — code-level specificity often lives in the MAC-level local coverage determination (LCD) supplements or in the annual Physician Fee Schedule billing guidelines.
That said, your billing team should be working with the following code categories for HCV screening billing. These are standard codes used in this context — verify them against your current payer-specific billing guidelines and the Medicare Physician Fee Schedule before the effective date.
Standard Codes Used for HCV Screening (Verify Against Current Fee Schedule)
| Code | Type | Description |
|---|---|---|
| Not listed in policy document | — | The policy does not specify applicable codes. Cross-reference your MAC's LCD and the Medicare Physician Fee Schedule for current applicable CPT, HCPCS, and ICD-10 codes for adult HCV screening. |
Your MAC — the Medicare Administrative Contractor for your region — is your best resource for code-level guidance when a national coverage policy modification doesn't specify codes directly. Pull the relevant LCD from your MAC's website and confirm the codes your practice is currently using map correctly to the updated coverage criteria.
Contact your MAC directly if the LCD hasn't been updated to reflect the May 15, 2026 modification. It's not uncommon for a national policy update to precede a MAC-level LCD revision by several weeks.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.